1. Home
  2. Recorded
Skip to main content
eLearning on BoehringerOne

Recorded

Hypertension Management Across the Full Patient Spectrum

Hypertension Management Across the Full Patient Spectrum

Management of Hypertension Across the Full Patient Spectrum

Management of Hypertension Across the Full Patient Spectrum

East meets West: Practical Guidance for Optimizing Stroke Prevention in AF Patients and the Role of Dabigatran

East meets West: Practical Guidance for Optimizing Stroke Prevention in AF Patients and the Role of Dabigatran

Key Insight from ESC/EHRA Guideline for AF Management

Key Insight from ESC/EHRA Guideline for AF Management

Hypertension Management Across the Full Patient Spectrum

Hypertension Management Across the Full Patient Spectrum

Secondary Prevention of Recurrent Stroke: A Case Study

Secondary Prevention of Recurrent Stroke: A Case Study

DPP4-inhibitors in T2DM: What does the EVIDENCE really say?

DPP4-inhibitors in T2DM: What does the EVIDENCE really say?

DPP4-inhibitors in T2DM: What does the EVIDENCE really say?

DPP4-inhibitors in T2DM: What does the EVIDENCE really say?

New Approach to T2DM: Do DPP4 inhibitors like linagliptin still fit in?

New Approach to T2DM: Do DPP4 inhibitors like linagliptin still fit in?

Understanding the role of SGLT2i in the full spectrum of Heart Failure

Understanding the role of SGLT2i in the full spectrum of Heart Failure

Role of EGFR TKIs in uncommon and compound  mutations

Role of EGFR TKIs in uncommon and compound mutations

Multiplex screening to detect uncommon and compound EGFR mutations

Multiplex screening to detect uncommon and compound EGFR mutations

Latest clinical research focus on the Targeted Therapy

Latest clinical research focus on the Targeted Therapy

Upfront EGFR TKIs Selection: 1st, 2nd, or 3rd Generation?

Upfront EGFR TKIs Selection: 1st, 2nd, or 3rd Generation?